Positron-emission tomography for surveillance of head and neck cancer.
about
Oral cavity and oropharyngeal squamous cell carcinoma--an updateFunctional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancersFluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective studyEarly detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.Early assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study.Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer.Comparison of positron emission tomography/computed tomography imaging and ultrasound in surveillance of head and neck cancer - The 3-year experience of the ENT Department in Poznan.Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.Role of PET/CT imaging in stereotactic body radiotherapy.Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck.Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.Positron emission tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma.The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.Newer imaging techniques in head and neck cancer.Diffusion-weighted imaging in head and neck squamous cell carcinomas: a systematic review.Basic principles and applications of (18)F-FDG-PET/CT in oral and maxillofacial imaging: A pictorial essay.Optimal timing of first posttreatment FDG PET/CT in head and neck squamous cell carcinoma.Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.Role of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Evaluation of Head and Neck Carcinoma.2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer.Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer.The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.Interpretability of PET/CT imaging in head and neck cancer patients following composite mandibular resection and osteocutaneous free flap reconstruction.Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
P2860
Q26799210-156613C8-3F01-47DA-AD94-685C452A9C38Q28075983-A565616C-44BC-4D78-9B99-F99DB1E1E847Q30884020-A0160DC2-AEB6-4E15-A591-480EB89EFB8EQ35673572-6A5047A0-1EC5-4426-8524-504C314357E3Q35840022-CD6CE5CB-56CE-4789-A545-28C0BF078101Q35925534-9C6D2277-17B3-4901-A699-A20F22C2428CQ37247189-0DFD42C0-A388-4C9E-B30D-E962CDADCD3DQ37254208-EAE43FE3-8236-4AE0-B7AE-52F95E7B988DQ37314625-9936FF63-8C23-48DD-A65F-4C96ACDDFE33Q37346348-7B21148E-4FCD-4900-8F8F-D5CC22A82BBCQ37392480-EB34183F-1B5C-415F-B602-A13248331A4BQ37608674-5A4EBF82-7E98-44D6-BC03-969A0CDA9B7FQ37690317-232CF131-884E-42D9-B120-79AA7E3B868CQ37870929-D239EC8D-6747-4192-83CA-7CF6799011E5Q37919750-A3A916C7-13A1-4BD5-9CBD-A76E84ABAC7EQ37921817-1867214B-5DF3-4BDB-9580-02DD1C5DE3F4Q38000079-58280E74-D8F1-432C-A4BE-C7C8295F4069Q38038842-AD886C5A-3FE0-48EA-84C9-F411D571541EQ38172079-C15D189C-C112-41D3-901E-A5D131C7206FQ38282917-9DD90F89-B85E-4E9C-810A-3AB1C0DA4565Q38445194-8FED6113-A9B0-42AE-80DC-25FE5DFC95C0Q38617866-631762B6-AB05-4348-834B-6987205A37B8Q42376455-DC2635AB-19D9-4A40-B467-DBA28B56274BQ42394201-9AB89A1D-1064-402C-83C5-49BBF076BD4EQ43946360-7E590A11-21CB-4305-AE3E-270AAA3FFF6CQ44222019-EAD8AA29-80AB-4A28-B37D-D6B585BF662AQ45376926-D94DC4D5-DA65-435E-B2E9-4D60BC347C9EQ45959221-EB4C56E4-B437-48F7-B04E-5EAB1740E242Q46141917-1A5BE638-A02A-4BF2-9125-26E5AA3B02E7Q46593013-5EF2D665-375C-4802-8591-67599EF3AA45Q46935608-F57A4E9A-62EE-447D-8D69-F34E628C238EQ48290814-B4B26DA6-3550-44CD-AFF5-B7B175500DD7Q50936941-9FFB9BE6-77FC-49C7-BBA2-39B13FF3053CQ53053341-147F6B76-0C37-4236-B2BF-28888BE43A2FQ53058273-714CD1E5-67D0-4ADF-99F7-65CE4D061F0FQ53140314-C7090A41-36EE-4521-BADD-FC2ED289CB73Q53174767-BEB6CAEF-02F8-43B1-A602-54567CDC897FQ53347813-919B3E78-4C30-4ED1-8287-098238B05263Q53475139-DFCC6AE6-3FC7-4982-822D-3A9BC75AE2F4Q53535987-CFDE12C1-46AC-4098-9CA4-B82DEDC189EA
P2860
Positron-emission tomography for surveillance of head and neck cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Positron-emission tomography for surveillance of head and neck cancer.
@ast
Positron-emission tomography for surveillance of head and neck cancer.
@en
type
label
Positron-emission tomography for surveillance of head and neck cancer.
@ast
Positron-emission tomography for surveillance of head and neck cancer.
@en
prefLabel
Positron-emission tomography for surveillance of head and neck cancer.
@ast
Positron-emission tomography for surveillance of head and neck cancer.
@en
P2093
P1433
P1476
Positron-emission tomography for surveillance of head and neck cancer.
@en
P2093
Harlan A Pinto
Quynh-Thu Le
Willard E Fee
William R Ryan
P304
P356
10.1097/01.MLG.0000161345.23128.D4
P407
P577
2005-04-01T00:00:00Z